(Q36831359)

16 August 2017

1 reference

title

Targeting of peripheral blood T lymphocytes (English)

1 reference

16 August 2017

R L Bolhuis

1

1 reference

PubMed ID

8908701

16 August 2017

H R Hoogenboom

series ordinal

2

1 reference

PubMed ID

8908701

16 August 2017

J W Gratama

series ordinal

3

1 reference

16 August 2017

1 January 1996

1 reference

Seminars in Immunopathology

16 August 2017

1 reference

16 August 2017

18

1 reference

16 August 2017

211-226

1 reference

16 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00820667

16 August 2017

0 references

cites work

Human T-lymphocytes targeted against an established human ovarian carcinoma with a bispecific F(ab')2 antibody prolong host survival in a murine xenograft model

1 reference

12 December 2020

Internal Disintegration Model of Cytotoxic Lymphocyte-Induced Target Damage

1 reference

12 December 2020

CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells

1 reference

12 December 2020

Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice

1 reference

12 December 2020

Role of T-cell subsets in the bispecific antibody (anti-idiotype x anti-CD3) treatment of the BCL1 lymphoma

1 reference

12 December 2020

Targeting human T-lymphocytes with bispecific antibodies to react against human ovarian carcinoma cells growing in nu/nu mice

1 reference

12 December 2020

Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains

1 reference

12 December 2020

Cytokine release in an ovarian carcinoma patient following intravenous administration of bispecific antibody OC/TR F(ab')2

1 reference

12 December 2020

T cell targeting in cancer therapy

1 reference

12 December 2020

Miniantibodies: use of amphipathic helices to produce functional, flexibly linked dimeric FV fragments with high avidity in Escherichia coli

1 reference

12 December 2020

T-cell-receptor-independent activation of cytolytic activity of cytotoxic T lymphocytes mediated through CD44 and gp90MEL-14.

1 reference

12 December 2020

By-passing immunization. Human antibodies from V-gene libraries displayed on phage

1 reference

12 December 2020

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

1 reference

12 December 2020

Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody

1 reference

12 December 2020

CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta

1 reference

12 December 2020

Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-type specificity

1 reference

12 December 2020

Making antibodies by phage display technology

1 reference

12 December 2020

The use of hybrid hybridomas to target human cytotoxic T lymphocytes.

1 reference

12 December 2020

Serial triggering of many T-cell receptors by a few peptide-MHC complexes

1 reference

12 December 2020

A central role of perforin in cytolysis?

1 reference

12 December 2020

The role of the Fas lytic pathway in a perforin-less CTL hybridoma.

1 reference

12 December 2020

Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo

1 reference

12 December 2020

The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster

1 reference

12 December 2020

High level secretion of a humanized bispecific diabody from Escherichia coli.

1 reference

12 December 2020

Susceptibility to cytotoxic T lymphocyte-induced apoptosis is a function of the proliferative status of the target

1 reference

12 December 2020

Treatment of mice bearing BCL1 lymphoma with bispecific antibodies

1 reference

12 December 2020

Specific elimination of IgE production using T cell lines expressing chimeric T cell receptor genes

1 reference

12 December 2020

The concept of immunological surveillance

1 reference

12 December 2020

Generation of effector T cells expressing chimeric T cell receptor with antibody type-specificity.

1 reference

12 December 2020

T-cell antigen receptor genes and T-cell recognition

1 reference

12 December 2020

Evidence for a physical association of CD4 and the CD3: α : β T-cell receptor

1 reference

12 December 2020

Formation of a bispecific antibody by the use of leucine zippers

1 reference

12 December 2020

A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene

1 reference

12 December 2020

Chimeric immunoglobulin-T cell receptor proteins form functional receptors: implications for T cell receptor complex formation and activation

1 reference

12 December 2020

New simplified molecular design for functional T cell receptor

1 reference

12 December 2020

Regulation of cytolytic activity in CD3- and CD3+ killer cell clones by monoclonal antibodies (anti-CD16, anti-CD2, anti-CD3) depends on subclass specificity of target cell IgG-FcR

1 reference

12 December 2020

Monoclonal antibody-mediated tumor regression by induction of apoptosis.

1 reference

12 December 2020

The CTL's kiss of death

1 reference

12 December 2020

Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes

1 reference

12 December 2020

Calcium is essential for both the membrane binding and lytic activity of pore-forming protein (perforin) from cytotoxic T-lymphocyte

1 reference

12 December 2020

Lymphocyte leukocyte function-associated antigen 1 interacting with target cell intercellular adhesion molecule 1 co-activates cytolysis triggered via CD16 or the receptor involved in major histocompatibility antigen-unrestricted lysis

1 reference

12 December 2020

Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogene

1 reference

12 December 2020

Bispecific antibody therapy of two murine B-cell lymphomas

1 reference

12 December 2020

Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library

1 reference

12 December 2020

Bispecific antibodies in lymphoma

1 reference

12 December 2020

Homology of perforin to the ninth component of complement (C9).

1 reference

12 December 2020

Isolation of high affinity human antibodies directly from large synthetic repertoires.

1 reference

12 December 2020

A T-cell receptor γ/CD3 complex found on cloned functional lymphocytes

1 reference

12 December 2020

Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors

1 reference

12 December 2020

"Diabodies": small bivalent and bispecific antibody fragments

1 reference

12 December 2020

Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report

1 reference

12 December 2020

Clustered CD3/TCR complexes do not transduce activation signals after bispecific monoclonal antibody-triggered lysis by cytotoxic T lymphocytes via CD3.

1 reference

12 December 2020

Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules

1 reference

12 December 2020

Analysis of production, purification, and cytolytic potential of bi-specific antibodies reactive with ovarian-carcinoma-associated antigens and the T-cell antigen CD3

1 reference

12 December 2020

The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis

1 reference

12 December 2020

Delivery of novel therapeutic agents in tumors: physiological barriers and strategies

1 reference

12 December 2020

The reorientation of the Golgi apparatus and the microtubule-organizing center in the cytotoxic effector cell is a prerequisite in the lysis of bound target cells

1 reference

12 December 2020

Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity

1 reference

12 December 2020

Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors

1 reference

12 December 2020

Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A

1 reference

12 December 2020

Adapting antibodies for clinical use.

1 reference

12 December 2020

Spatial relationships of microtubule-organizing centers and the contact area of cytotoxic T lymphocytes and target cells

1 reference

12 December 2020

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

1 reference

12 December 2020

Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells

1 reference

12 December 2020

Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells.

1 reference

12 December 2020

Diminution of antibodies directed against tumor cell surface epitopes: a single chain Fv fusion molecule specifically recognizes the extracellular domain of the c-erbB-2 receptor

1 reference

12 December 2020

Treatment of murine B cell lymphoma with bispecific monoclonal antibodies (anti-idiotype x anti-CD3)

1 reference

12 December 2020

A bispecific antibody prolongs survival in mice bearing lung metastases of syngeneic mammary adenocarcinoma

1 reference

12 December 2020

Identification of a monoclonal antibody specific for a murine T3 polypeptide

1 reference

12 December 2020

Roles of multiple accessory molecules in T-cell activation

1 reference

12 December 2020

Bispecific IgG and IL-2 therapy of a syngeneic B-cell lymphoma in immunocompetent mice

1 reference

12 December 2020

Coclustering of CD4 (L3T4) molecule with the T-cell receptor is induced by specific direct interaction of helper T cells and antigen-presenting cells

1 reference

12 December 2020

In vivo tumor targeting of a recombinant single-chain antigen-binding protein

1 reference

12 December 2020

The role of the CD28 receptor during T cell responses to antigen

1 reference

12 December 2020

Perforin-mediated target cell lysis by cytolytic T lymphocytes

1 reference

12 December 2020

Phosphorylation of CD4 and CD8 molecules following T cell triggering.

1 reference

12 December 2020

Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytes

1 reference

12 December 2020

Expression of chimeric receptor composed of immunoglobulin-derived V regions and T-cell receptor-derived C regions.

1 reference

12 December 2020

Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes

1 reference

12 December 2020

Regression of advanced ovarian carcinoma by intraperitoneal treatment with autologous T lymphocytes retargeted by a bispecific monoclonal antibody

1 reference

12 December 2020

Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients

1 reference

12 December 2020

Adoptive immunotherapy of ovarian carcinoma with bs-MAb-targeted lymphocytes: a multicenter study

1 reference

12 December 2020

A conformational epitope expressed upon association of CD3-epsilon with either CD3-delta or CD3-gamma is the main target for recognition by anti-CD3 monoclonal antibodies

1 reference

12 December 2020

Lysis of ovarian cancer cells by human lymphocytes redirected with a chimeric gene composed of an antibody variable region and the Fc receptor gamma chain

1 reference

12 December 2020

Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma

1 reference

12 December 2020

Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors.

1 reference

12 December 2020

Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2.

1 reference

12 December 2020

The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins

1 reference

12 December 2020

Single-chain antigen-binding proteins

1 reference

12 December 2020

1 reference

12 December 2020

Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes

1 reference

12 December 2020

Endowing T cells with antibody specificity using chimeric T cell receptors

1 reference

12 December 2020

Antibodies to CD44 trigger effector functions of human T cell clones

1 reference

12 December 2020

Human peripheral blood lymphocytes targeted with bispecific antibodies release cytokines that are essential for inhibiting tumor growth

1 reference

12 December 2020

Targeting and activation of cytotoxic lymphocytes

1 reference

12 December 2020

Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1

1 reference

12 December 2020

CD44 and its interaction with extracellular matrix.

1 reference

12 December 2020

Phage antibodies: filamentous phage displaying antibody variable domains

1 reference

12 December 2020

Immunotherapy in a human ovarian cancer xenograft model with two bispecific monoclonal antibodies: OV-TL 3/CD3 and OC/TR

1 reference

12 December 2020

Engineering bispecific antibodies

1 reference

12 December 2020

Structure and function of human perforin

1 reference

12 December 2020

Functional diversity of T lymphocytes due to secretion of different cytokine patterns

1 reference

12 December 2020

By-passing immunisation. Human antibodies from synthetic repertoires of germline VH gene segments rearranged in vitro

1 reference

12 December 2020

Folate-binding protein is a marker for ovarian cancer

1 reference

12 December 2020

Adhesion receptors of the immune system

1 reference

12 December 2020

Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin 2

1 reference

12 December 2020

Cytotoxic T lymphocytes with a grafted recognition specificity for ERBB2-expressing tumor cells

1 reference

12 December 2020

T-cell retargeting using bispecific monoclonal antibodies in a rat colon carcinoma model. I. Significant bispecific lysis of syngeneic colon carcinoma CC531 is critically dependent on prolonged preactivation of effector T-lymphocytes by immobilized

1 reference

12 December 2020

Induction of lysis by T cell receptor gamma delta+/CD3+ T lymphocytes via CD2 requires triggering via the T11.1 epitope only

1 reference

12 December 2020

Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.

1 reference

12 December 2020

The role of T cell activation in anti-CD3 x antitumor bispecific antibody therapy.

1 reference

12 December 2020

The outline structure of the T-cell alpha beta receptor.

1 reference

12 December 2020

The ups and downs of T cell costimulation

1 reference

12 December 2020

Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice

1 reference

12 December 2020

ICAM- melanoma cells are relatively resistant to CD3-mediated T-cell lysis

1 reference

12 December 2020

Induction and blocking of cytolysis in CD2+, CD3- NK and CD2+, CD3+ cytotoxic T lymphocytes via CD2 50 KD sheep erythrocyte receptor

1 reference

12 December 2020

Identification of a murine monoclonal antibody specific for an allotypic determinant on mouse CD3

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00820667

1 reference

16 August 2017

1 reference

PubMed ID

8908701